Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | compounds already reach it: carglumic acid | 1.00 |
| trials ClinicalTrials.gov | 17 Parkinson's trials, 1 stopped | 0.95 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 3 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 15636
Sealed predictions
- CPS1 in dopamine neurons, braak+0.40 (p 0.284) → +0.05 (p 0.892)receipt 15642
Swarm cases
receipt 15642: CPS1 in dopamine neurons, braak
- power
- full sample +0.16 (p 0.532, n 18), 95% CI -0.33 to +0.58. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.16 (p 0.532, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.17 (p 0.493, n 18). could be the mix.
- skeptic
- leave-one-out range +0.06 to +0.30, sign flips 0; without severely affected donors +0.16 (p 0.532, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CPS1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts